• A Global Health Tidal Wave? Cardiorenal Metabolic Syndrome

  • Jun 18 2024
  • Length: 27 mins
  • Podcast

A Global Health Tidal Wave? Cardiorenal Metabolic Syndrome cover art

A Global Health Tidal Wave? Cardiorenal Metabolic Syndrome

Listen for free

View show details

  • Summary

  • Join Drs Nihar Desai and Chiadi Ndumele as they define and discuss cardiorenal metabolic syndrome, a chronic health condition with the potential to impact up to 90% of the US population.

    Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999839. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association https://pubmed.ncbi.nlm.nih.gov/37807924/

    American Heart Association PREVENTTM Online Calculator https://professional.heart.org/en/guidelines-and-statements/prevent-calculator

    Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020 https://pubmed.ncbi.nlm.nih.gov/38717747/

    2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines https://pubmed.ncbi.nlm.nih.gov/24222018/

    Renoprotection With SGLT2 Inhibitors in Type 2 Diabetes Over a Spectrum of Cardiovascular and Renal Risk https://pubmed.ncbi.nlm.nih.gov/33222693/

    Cardiovascular and Kidney Outcomes With Finerenone in Patients With Type 2 Diabetes and Chronic Kidney Disease: The FIDELITY Pooled Analysis https://pubmed.ncbi.nlm.nih.gov/35023547/

    Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% (FINEARTS-HF) https://classic.clinicaltrials.gov/ct2/show/NCT04435626

    Novo Nordisk Will Stop the Once-Weekly Injectable Semaglutide Kidney Outcomes Trial, FLOW, Based on Interim Analysis https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=166327

    Long-Term Kidney Outcomes of Semaglutide in Obesity and Cardiovascular Disease in the SELECT Trial https://pubmed.ncbi.nlm.nih.gov/38796653/
    Show More Show Less
Physical Illness & Disease Hygiene & Healthy Living Science
Show More Show Less

What listeners say about A Global Health Tidal Wave? Cardiorenal Metabolic Syndrome

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.